The UK Government is funding a study which will involve 5,000 people from some of Scotland’s most deprived areas being given Wegovy injections.

Critics will understandably raise concerns about the cost to the NHS of giving out these injections. Wegovy is a weight loss ...

Novo Nordisk’s Wegovy (semaglutide) was launched in India in June 2025 specifically for obesity. Besides, Novo Nordisk’s ...

EXCLUSIVE: Scottish Labour Health Minister Zubir Ahmed said obesity is a "disease of poverty" and claimed the medications could cut the sickness benefits bill.

Ozempic, Mounjaro and Wegovy are now cultural symbols of weight loss. These medications help control blood sugar and aid weight loss. Ozempic is for t ...

Groundbreaking GLP-1 drugs like Ozempic, Mounjaro and Wegovy are revolutionising weight loss, with studies showing ...

After the injection, do not rub the area ... In a comparative clinical trial between Maunza and Wegovy conducted over 72 ...

Lilly’s quarterly results Thursday, combined with Novo Nordisk’s unsolicited offer for a startup, confirm the $72 billion ...

A major international study led by researchers at University College London has found that semaglutide, the active ingredient ...

Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems ...

Judging from the numbers I'm seeing, the black market for weight-loss jabs isn't small-scale. This is a massive operation.